[Lynch syndrome and risk of prostate cancer; review of the literature]

Prog Urol. 2015 Apr;25(5):225-32. doi: 10.1016/j.purol.2015.01.001. Epub 2015 Jan 29.
[Article in French]

Abstract

Introduction: The association between Lynch syndrome and prostate cancer has been studied. Recent studies report an association between these two diseases.

Material and methods: Literature review based on PubMed search was performed using the following keywords: Lynch syndrome and prostate cancer.

Results: Eight articles analyzing cohorts of subjects carrying Lynch syndrome were analysed including 6786 patients with 175 cancers. Prostate cancers were more frequent with a standardized incidence ratio (SIR) from 0.93 (95% CI: 0.19-2.7) and 5.9 (95% CI 4.1-17.1) and occurs at a younger age than in the general population mainly for mutations in the MSH2 gene.

Conclusion: Prostate cancer seem more frequent and occur earlier in individuals harboring a mutation in the MSH2 gene while it does not appear to be any difference compared to the general population for other mutations in Lynch syndrome.

Keywords: Cancer de prostate; Déficience du système mismatch repair; Instabilité des microsatellites; Lynch syndrome; Microsatellite instability; Mismatch repair deficiency; Prostate cancer; Syndrome de Lynch.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Colorectal Neoplasms, Hereditary Nonpolyposis / complications*
  • Colorectal Neoplasms, Hereditary Nonpolyposis / genetics
  • Evidence-Based Medicine
  • France / epidemiology
  • Humans
  • Incidence
  • Male
  • MutS Homolog 2 Protein / genetics*
  • Mutation*
  • Practice Guidelines as Topic
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / epidemiology*
  • Prostatic Neoplasms / genetics
  • Risk Factors

Substances

  • MSH2 protein, human
  • MutS Homolog 2 Protein